Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Non-Staff Directors Get 50-Percent Raise; Increase Brings Remuneration to $30K Per Director

NEW YORK, Jan. 7 (GenomeWeb News) - Non-employee Affymetrix directors will get a 50-percent increase in the annual fee the company pays them for their services, Affymetrix said in a filing with the US Securities and Exchange Commission yesterday.


The six non-employee members will receive $30,000 a year, up from $20,000, the company said.


The company's non-employee directors are: Susan Desmond-Hellmann, president of product development at Genentech; John Diekman, managing partner of 5AM Ventures; Vernon Loucks, chairman of The Athena Group; David Singer, chairman of Oscient Pharmaceuticals; and John Young, retired president and CEO of Hewlett-Packard.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.